• Episode 6: The OPTIC study: Patient views on optimising immunotherapy in cancer

  • Jul 1 2024
  • Durée: 25 min
  • Podcast

Episode 6: The OPTIC study: Patient views on optimising immunotherapy in cancer

  • Résumé

  • Optimisation immunotherapy clinical trials investigate ways of reducing the intensity of immunotherapy cancer treatment. This could be beneficial for patients’ quality of life. But these trials can be challenging to run, as patients may be concerned about the impact that reducing the intensity of treatment could have on the cancer.

    This episode of the Trial Talk podcast focuses on the MRC Clinical Trials Unit at UCL’s OPTIC study, which explores how people with cancer feel about taking part in optimisation immunotherapy trials. Clinical Fellow Sophie Merrick discusses the main barriers that patients face and recommendations to address them.

    Resources:
    •OPTIC study page: www.mrcctu.ucl.ac.uk/studies/all-st…/refine/optic/
    •OPTIC results paper: www.nature.com/articles/s41416-024-02756-x.pdf
    •REFINE podcast episode: on.soundcloud.com/Fe3C76csHkgCg2or5

    For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk

    For more information and to access the transcript: bit.ly/4c9SfAr

    As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g

    Date of episode recording: 2024-06-18T00:00:00Z
    Duration: 00:25:23
    Language of episode: English
    Presenter: Berta Terre-Torras
    Guests: Sophie Merrick
    Producer: Berta Terre-Torras

    Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2

Ce que les auditeurs disent de Episode 6: The OPTIC study: Patient views on optimising immunotherapy in cancer

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.